Tachycardia Ventricular clinical trials

Explore recruiting tachycardia ventricular clinical trials.

Recruiting tachycardia ventricular studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Tachycardia Ventricular trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Impact of beta blocker administration on outcome among patients undergoing transcatheter aortic valve replacement - B-TAVR

Austria, Germany

Therapeutic use (Phase IV) EU CTIS Study details

Evaluation of postoperative recovery when combining intravenous lidocaine with ropivacaine infiltration in laparoscopic colorectal oncologic surgery: a randomized controlled trial

France

Therapeutic use (Phase IV) EU CTIS Study details

Effect of early use of levosimendan versus placebo on top of a conventional strategy of inotrope use on a combined morbidity-mortality endpoint in patients with cardiogenic shock. LevoHeartShock

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2a, Open-label, Pilot Study to Evaluate Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of MYK-224 in Participants with Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction (MERCUTIO)

Poland, Italy, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Long-term Safety Extension Study of Mavacamten (MYK-461) in Adults with Hypertrophic Cardiomyopathy Who Have Completed the MAVERICKHCM (MYK-461-006) or EXPLORER-HCM (MYK-461-005) Trials (MAVA-LTE)

Spain, Netherlands, Denmark, France, Belgium, Czechia +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Tachycardia Ventricular trials by city

Tachycardia Ventricular in Toronto Tachycardia Ventricular in Vancouver Tachycardia Ventricular in Montreal Tachycardia Ventricular in Calgary Tachycardia Ventricular in Edmonton Tachycardia Ventricular in Ottawa Tachycardia Ventricular in Winnipeg Tachycardia Ventricular in Quebec City Tachycardia Ventricular in Hamilton Tachycardia Ventricular in Kitchener Tachycardia Ventricular in London Tachycardia Ventricular in Halifax Tachycardia Ventricular in New York Tachycardia Ventricular in Los Angeles Tachycardia Ventricular in Chicago Tachycardia Ventricular in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease